Management of Aamavata through Ayurveda

CLINICAL STUDY OF SHTAYADI KWATHA IN THE MANAGEMENT OF AAMAVATA (RHEUMATOID ARTHRITIS) - RA

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033222

Enrollment

Registered

2021-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Shtayadi Kwatha: Shtayadi Kwatha in the dose of 20 ml twice a day for 90 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed and Confirmed Cases of Aamavata (Rheumatoid Arthriris) on the basis of sign and symptoms.

Exclusion criteria

Exclusion criteria: Patient below 20 and above 60 years. Pregnant women and Lactating Mother. Patients Suffering from serious Systemic disorders like Hypertension, Cardiac and Renal Disorder, Malignant Disease, Diabetes Mellitus, Major Liver Disorder, Immune compromised host,etc

Design outcomes

Primary

Measure	Time frame
Improvement in Subjective and Objective parametersTimepoint: 90 Days	—

Secondary

Measure	Time frame
To Find out the Efficacy of TreatmentTimepoint: 90 Days	—

Countries

India

Contacts

Public ContactDr Garima Yadav

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026